Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune Hepatitis / 대한소아소화기영양학회지

Predictors of renal replacement therapy and mortality in children with chronic kidney disease

To study the epidemiology of chronic kidney disease [CKD] in children, and to look for risk factors to predict renal replacement therapy [RRT] and mortality. This is a retrospective cohort study conducted at King Abdulaziz University Hospital, Jeddah, Saudi Arabia between 2006 and 2014, where the files of 1,000 children with CKD were reviewed. We determined the effect of consanguinity and hypertension, and being a Saudi indigene on mortality and RRT. We compared children with congenital versus non-congenital causes of CKD. The mean +/- standard deviation age at presentation was 4.9 +/- 4.3 years. The median duration of follow up was 1.5 [interquartile range [IQR]: 0.4-4.0] years. Only 9.7% of children received RRT, and 8.3% died. The underlying etiology for CKD was congenital in 537 children. The congenital CKD group presented at a younger age group [3.5 +/- 4.0 versus 6.6 +/- 3.9 years, p<0.0001], had more advanced stages of CKD [p<0.0001], higher rates of consanguinity [75.4% versus 47.1%, p<0.0001], and RRT [p<0.004] than children with non-congenital CKD. Risk factors for RRT among children with CKD include being a Saudi indigene [relative risk [RR]=1.49, 95% confidence interval [CI]: 1.01-2.21], and hypertensive [RR=5.29, 95% CI: 3.54-7.91]. The risk factor for mortality was hypertension [RR=2.46, 95% CI: 1.66-3.65]. Congenital causes of CKD represent the main etiology of CKD in children living in the western province of Saudi Arabia. Significant risk factors for RRT include congenital CKD, Saudi nationality, and hypertension. Hypertension is also a predictor of mortality in children with CKD

Vesicoureteric reflux in children

This study aimed to identify the differences between primary and secondary vesicoureteric reflux [VUR] and the effect of associated bladder abnormalities on kidney function. We retrospectively reviewed the medical records of children with VUR who were followed up at King Abdulaziz University Hospital from January 2005 to December 2010. The review included results of radiological investigations and kidney function tests. We used Chi-square test for statistical analysis and paired t-test to compare group means for initial and last creatinine levels. Ninety-nine children were included in this study. Twenty [20.2%] had primary VUR, 11 had high-grade VUR, while 9 had low-grade reflux. All children with low-grade VUR had normal dimercaptosuccinic acid [DMSA]. Renal scars were present in 72% of the children with high-grade VUR. The mean creatinine levels [initial and last] for both groups were normal. Seventy-nine [79.8%] children had secondary VUR, which was due to posterior urethral valves [PUV] [46.8%], neurogenic bladder caused by meningomyelocele [25.3%], non-neurogenic neurogenic bladder [NNB] [21.5%], or neurogenic bladder associated with prune belly syndrome [6.3%]. Children with NNB, meningomyelocele and PUV had high creatinine at presentation with no considerable worsening of their kidney functions during the last visit. Renal scars were present in 49.4% of the children with secondary VUR. Children with primary VUR and normal bladder had good-functioning kidneys, while those with secondary VUR associated with abnormal bladder caused by NNB, spina bifida or PUV had abnormal kidney functions. DMSA scans were useful in predicting higher grades of VUR in children with primary reflux

Effect of calcium antagonists on left ventricular and ventilatiory functions in patients with ischaemic heart and obstructive airway disease

The aim of this study is to assess the effect of calcium antagonists on left venticular and ventilatory functions in patients with ischaemic heart disease associated with obstructive lung disease. The material of this work comrised [10] healthy subject as a control group and [20] patients with symtomatizing ischaemic heart disease associated with obstructive airways diseases- as a test group, the test group was divided into two subgroups, one assigned for use of Verapamil [10] patients and the other for Nifedipine [10] patients. After taking detailed clinical history and parforming careful physical examination, all patients were subjected to, urine and stool analysis, fasting blood sugar X- ray film ECG, measurements of systolic time intervals [STIs] including [Q-S21], PEP1, LVET and PEP/ LVET ratio] and ventilatory function tests, including [FVC, FEV1 and FEV1/FVC%]. STIs and ventilatory parameters were done before and in the 10[th] day of using either Verapamil or Nifedipine. Comparative analysis of STIs in both subgroups assigned for use of either Verapamil or Nifedipine showed left ventricular dysfunction as shown from the significant prolongation of PEPI, shortening of LVET and rise in PEP/LVET ratio, also insignificant prolongation of Q-S21 was observed, indicating mild left ventricular dysfunction. On the other hand, comparing the same parameters of STIs after versus before use of either Verapamil or Nifedipine. Showed no significant prolongation of PEPI, shortening of LIVT1 or rise in PEP/LVET ratio. Comparative analysis of ventilatory parameters after versus before the use either Verapamil or Nifedipine Showed non-significant changs. It may be concluded, that left ventricular dysfunction is found in patients with ischaemic heart disease associated with obstructive airways disease, and the use of either Verapamil or Nifedipins drugs is safe in such patients, as they produces mild negative inotropy and left ventricular dysfunction which were short of significance and negligable in comparison to its benificial effect, on the other hand have no adverse or improving effect on ventilatory function in patients with chronic obstructive airway diseases